CYSLTR1 and allergic disease: Based on the pivotal roles of LTs in inflammation and allergy, drugs interfering with either LT receptors (i.e., cysLT1) or with their biosynthesis have been developed for the treatment of asthma, allergies, arthritis, and cardiovascular disease (Haeggstrom, 2018).